These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19763673)

  • 21. Proton pump inhibitors.
    Katelaris PH
    Med J Aust; 1998 Aug; 169(4):208-11. PubMed ID: 9734580
    [No Abstract]   [Full Text] [Related]  

  • 22. Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors.
    Miner PB; McKean LA; Gibb RD; Erasala GN; Ramsey DL; McRorie JW
    Aliment Pharmacol Ther; 2010 Apr; 31(8):846-51. PubMed ID: 20146702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective trial of laparoscopic nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: Seven-year follow-up.
    Mehta S; Bennett J; Mahon D; Rhodes M
    J Gastrointest Surg; 2006 Nov; 10(9):1312-6; discussion 1316-7. PubMed ID: 17114017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton pump inhibitors: a survey of prescribing in an Irish general hospital.
    Mat Saad AZ; Collins N; Lobo MM; O'Connor HJ
    Int J Clin Pract; 2005 Jan; 59(1):31-4. PubMed ID: 15707461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic innovations in gastroesophageal reflux].
    Bigard MA
    Presse Med; 2007 Dec; 36(12 Pt 3):1907-12. PubMed ID: 17531431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and pharmacodynamics of lansoprazole in patients with gastroesophageal reflux disease aged <1 year.
    Springer M; Atkinson S; North J; Raanan M
    Paediatr Drugs; 2008; 10(4):255-63. PubMed ID: 18590344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012.
    Moriarty F; Bennett K; Cahir C; Fahey T
    J Am Geriatr Soc; 2016 Dec; 64(12):e291-e296. PubMed ID: 27996115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are the orally administered proton pump inhibitors equivalent? A comparison of lansoprazole, omeprazole, pantoprazole, and rabeprazole.
    Thomson AB
    Curr Gastroenterol Rep; 2000 Dec; 2(6):482-93. PubMed ID: 11079051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of proton pump inhibitors anti-ulcer drugs use in the Araba district primary care area].
    Martínez Gorostiaga J; Echevarría Orella E; Calvo Hernáez B
    Rev Esp Salud Publica; 2018 Aug; 92():. PubMed ID: 30100604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of long-term treatment with proton pump inhibitors in gastro-oesophageal reflux disease on the histological findings in the lower oesophagus.
    Stolte M; Vieth M; Schmitz JM; Alexandridis T; Seifert E
    Scand J Gastroenterol; 2000 Nov; 35(11):1125-30. PubMed ID: 11145281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A questionnaire on prescription patterns of proton pump inhibitors for hemodialysis patients in Japan.
    Kawarazaki H; Nakashima A; Furusho M; Shimizu S; Nakata T
    Clin Exp Nephrol; 2020 Jun; 24(6):565-572. PubMed ID: 32147803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [All proton pump inhibitors are equally efficacious in standard dosages].
    Hellström PM; Vitols S
    Lakartidningen; 2003 Jun; 100(25):2212-6. PubMed ID: 12872509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [General practitioners' management of gastroesophageal reflux in France in 2005: a pharmacoeconomic study].
    Mouly S; Charlemagne A; Le Jeunne P; Fagnani F
    Presse Med; 2008 Oct; 37(10):1397-406. PubMed ID: 18502602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective follow-up study of 5669 users of lansoprazole in daily practice.
    Leufkens H; Claessens A; Heerdink E; van Eijk J; Lamers CB
    Aliment Pharmacol Ther; 1997 Oct; 11(5):887-97. PubMed ID: 9354197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prescribing of Proton Pump Inhibitors in an Irish General Practice.
    O’Mahony L; Yelverton E
    Ir Med J; 2019 May; 112(5):932. PubMed ID: 31411014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evaluation of the clinical implications of acid breakthrough in patients on proton pump inhibitor therapy.
    Nzeako UC; Murray JA
    Aliment Pharmacol Ther; 2002 Jul; 16(7):1309-16. PubMed ID: 12144581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole.
    Baldi F; Cappiello R; Cavoli C; Ghersi S; Torresan F; Roda E
    World J Gastroenterol; 2006 Jan; 12(1):82-8. PubMed ID: 16440422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Speed of onset of oesophageal acid reduction with different proton-pump inhibitors in patients with reflux oesophagitis.
    Newton M; Burnham WR; Kamm MA
    Eur J Gastroenterol Hepatol; 1998 Sep; 10(9):753-8. PubMed ID: 9831269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.
    Jaspersen D; Diehl KL; Schoeppner H; Geyer P; Martens E
    Aliment Pharmacol Ther; 1998 Jan; 12(1):49-52. PubMed ID: 9692700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.